Comparative study between oxytocin versus combination of tranexamic acid and ethsmyslate in reducing intra operative bleeding during abdominal myomectomy
Not Applicable
- Conditions
- controlling bleeding after myomectomy
- Registration Number
- PACTR202008739887429
- Lead Sponsor
- Elgalaa teaching hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- Female
- Target Recruitment
- 180
Inclusion Criteria
premenopausal patients
aged between 30 to 50 years old,
five or less symptomatic uterine myomas,
maximum diameter of the largest myoma is 6 cm,
all myomas are subserous or intramural and uterine size less than 24 weeks pregnancy
Exclusion Criteria
history of previous surgery, hypertension, cardiac and Pulmonary diseases,
patients who have bleeding disorders,
anemia (Hb< 10g %),
chronic endocrine or metabolic diseases such as Diabetes, obesity (body mass index > 30 kg/m²)
cases that require intraoperative conversion of myomectomy to hysterectomy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method